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Accepted 27 January 2016Objective: Parkinson's disease is associated with high rates of depression. There is growing interest in non-
pharmacological management including psychological approaches such as Cognitive Behaviour Therapy. To
date, little research has investigated whether processes that underpin cognitive models of depression, on
which such treatment is based, apply in patients with Parkinson's disease. The study aimed to investigate the
contribution of core psychological factors to the presence and degree of depressive symptoms.
Methods: 104 participants completed questionnaires measuring mood, motor disability and core psychological
variables, including maladaptive assumptions, rumination, cognitive-behavioural avoidance, illness representa-
tions and cognitive-behavioural responses to symptoms.
Results: Regression analyses revealed that a small number of psychological factors accounted for the majority of
depression variance, over and above that explained by overall disability. Participants reporting high levels of
rumination, avoidance and symptom focusing experienced more severe depressive symptoms. In contrast,
pervasive negative dysfunctional beliefs did not independently contribute to depression variance.
Conclusion: Speciﬁc cognitive (rumination and symptom focusing) and behavioural (avoidance) processes may
be key psychological markers of depression in Parkinson's disease and therefore offer important targets for
tailored psychological interventions.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Depression is common in Parkinson's disease, with over one third
having a depressive disorder, subsyndromal depressive symptomatolo-
gy or signiﬁcant psychological distress [1]. There has been a welcome
advance in the number and quality of randomised controlled trials
(RCTs) of antidepressants, although a recent meta-analysis identiﬁed
only small to moderate effect sizes [2], and the non- and partial-
response rates to antidepressant medication are typically high in older
adults and those with chronic physical health problems [3]. Manage-
ment is further constrained by the potential for adverse drug interac-
tions [4], evidence for suboptimal treatment by clinicians [5] and the
facts that patients themselves express concerns about antidepressant
medication [6,7] with poor treatment adherence [8].
Explanations for depression in Parkinson's disease have typically
focussed on potential biological based mechanisms with disturbances
of brain monoamine systems [9]. However, the response to
pharmacological treatments, and other evidence suggests a broader
bio-psychosocial formulation is needed, both to deﬁne factors that
may cause and maintain depression in the context of a progressiveology and Neuroscience, PO77,
n).
. This is an open access article underand disabling condition, and to guide the development of effectiveman-
agement [10]. Evidence supports an association between psychological
and social factors and the presence and severity of depression in
Parkinson's disease. For example, cognitive and behavioural avoidance
as a coping response to illness related stressors, and negative illness rep-
resentations are associated with depression, while active task-oriented
coping tends to be associated with greater psychological well-being
[11–14]. While not necessarily causal, such factors may alter the risk
of depression onset and relapse or serve to maintain symptoms. Such
evidence has stimulated exploration of psychological approaches, par-
ticularly Cognitive Behaviour Therapy (CBT), as a potential alternative
or adjunct to pharmacotherapy. Trial evidence [15,16] suggests that sig-
niﬁcant treatment effects can be obtained [17], while the ﬂexibility for
delivering treatment in groups, by telephone [18] or via the internet, of-
fers opportunity to reach a large number of patients, economically and
in a way that some may prefer [6].
While evidence suggests that CBT can be effective, there are
challenges where mood problems exist in the context of an objectively
progressive and disabling condition with complex morbidity. Negative
and unhelpful beliefs and assumptions, are central to the Cognitive
Model of depression and a key treatment target [19]. However, the na-
ture and content of such thoughts may be realistic in a chronic disease,
and it is unknown whether they form a logical or useful therapeutic
target in Parkinson's disease. Other potential targets may includethe CC BY license (http://creativecommons.org/licenses/by/4.0/).
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repetitive thought processes such as worry and rumination [20–23].
All of these may serve as vulnerability factors, and/or become activated
in the context lowmood to helpmaintain a depressive episode. There is
the potential to modify CBT so that it targets those processes that
contribute most to depression onset, maintenance and/or relapse,
while reducing emphasis and time spent on less relevant elements of
therapy.
The present study aimed to assess the relative contribution of a
range of psychological factors either known to be associated with de-
pression in Parkinson's disease, or predicted by the Cognitive Model
that underpins conventional CBT. The results may support the value of
current CBT approaches or suggest alternatives or adaptations with
the potential to improve outcome.Methods
Participants
Participantswith a clinical diagnosis of Parkinson's disease [24]were
recruited via an existing research cohort (‘Prospective Study of Mood
States in Parkinson's Disease’ (PROMS-PD), Ethics Ref: 07/MRE01/9,
UKCRN ID: 2519) [25]. The full cohort of 513 represented a consecutive
series of consenting participants recruited over a 12month period from
specialist Parkinson's disease orMovement Disorder clinics in a number
of centres in England and Wales. They had a mean age of 67.9 years
(SD = 10.3, Range = 32–94 years) and 65% were male. Mean duration
of PD was 6.9 years (SD = 6.0, Range = 0–39 years). Signiﬁcant cogni-
tive impairment (MMSE ≤24) [26] was present in 10.2%. Almost all par-
ticipants in the cohort (94.9%)were taking antiparkinsonianmedication
at the time of recruitment.
From this cohort, participants for the present study were excluded if
they had no given consent to be re-contacted about other studies; if
they had a history of psychiatric disorder other than mood or anxiety
disorder; a history ofmajor neurological disorder other thanParkinson's
disease (e.g. stroke), or a score of 24 or less on theMMSE [26]. Addition-
ally, cohort participants who had been assessed as part of the main
PROMS-PD study or other supplementary study within the previous
3monthswere not approached to avoid over-testing. Written informed
consent was obtained from all participants. Ethical approval for the
study was granted by the South London Research Ethics Committee 4
(Reference 10/H0807/60).Assessment
Consenting participants completed a set of postal questionnaires
assessing demographic and disease-related information, mood and
psychological factors.
General physical health was measured using the physical health
subscale from the Duke Older Americans Resources and Services
(OARS) Multidimensional Functional Assessment Questionnaire
(OMFAQ) [27]. Parkinson's disease related disability was assessed as a
proxy for total motor and non-motor symptom burden using the
Parkinson's Activities of Daily Living Scale (PADLS). The scale has been
shown to correlate with clinical ratings of disease severity (r = 0.68)
and duration (r = 0.39) [28].
Self-reported depressive symptoms were assessed using the Beck
Depression Inventory Second Edition (BDI-II) [29], with a score of ≥14
indicating signiﬁcant symptoms [30,31]. A set of psychological factors
were assessed. These were selected to cover a range of psychological
constructs relevant to models of depression in general and in the con-
text of a physical health condition. Where appropriate, for some mea-
sures, minor changes were made to the wording of the instructions
and scale items to make them appropriate to older adults with PD.1. The 24-item Dysfunctional Attitude Scale (DAS-24) [32] a self-report
measure of general (rather than situation speciﬁc) unhelpful beliefs
that an individual may hold about themselves, the outside world or
their future, relating to aspects of personal achievement, dependency
on others and self-control (e.g. ‘My happiness depends more on
other people than it does on me’, ‘If I do not do as well as other
people, it means I am an inferior human being’).
2. The Ruminative Responses Scale (RRS) from the Response Styles
Questionnaire [33] is a 22-item scale, which assesses the general ten-
dency to respond to negative emotions with ruminative thoughts,
e.g. going somewhere to be alone and think about your feelings,
dwelling or how sad you feel, or pondering vague questions such as
‘what am I doing to deserve this?’. Rumination is considered a
metacognitive process (thinking about thinking and feelings)
where the focus is the thinking style rather than the thought content.
3. The Cognitive and Behavioral Avoidance Scale (CBAS) [34] is a
31-item multi-dimensional measure of cognitive and behavioural
avoidance, i.e. not thinking about or engaging in certain actions, or
efforts to escape from situations, as a means of minimizing threat
and distress. It has four reliable factors, Behavioral Social Avoidance
(e.g. ‘I do not go out to events when I know there be a lot of people
I do not know’), BehavioralNon-social Avoidance (e.g. I quit activities
that challenge me too much), Cognitive Social Avoidance (e.g. ‘I just
wait out tension in my relationships hoping that it will go away’)
and Cognitive Non-social Avoidance (e.g. ‘I avoid making decisions
about my future’).
4. The Revised Illness Perceptions Questionnaire (IPQ-R) [35] assesses
dimensions of illness perceptions across a range of health conditions,
focussed here on the participant's Parkinson's disease. The IPQ-R as-
sesses aspects of the individual's personal beliefs and understanding
through which they seek to make sense of their health condition: its
nature and deﬁning symptoms (identity), beliefs about cause(s), its
timeline (acute or chronic), its consequences and long-term impact,
and beliefs about control. These are assessed through a series of
subscales. Following previous research on the instrument's proper-
ties in Parkinson's disease [36], four disease related symptoms were
added to the existing checklist on the Identity subscale. An Emotional
Representations subscale in the original was not used as it was
judged to be very close conceptually to depression and might
therefore bias data interpretation.
5. The Cognitive and Behavioural Responses to Symptoms Question-
naire (CBSQ) [37] is a measure of beliefs and behavioural responses
to symptoms of their health condition. The form used measured
ﬁve cognitive (belief) subscales: Fear Avoidance Beliefs (‘I am afraid
that I will make my symptoms worse if I exercise’), Catastrophizing
Beliefs (‘I worry that I may become permanently bedridden because
of my symptoms’; Damage Beliefs (e.g. ‘symptoms are a signal that I
am damaging myself’), Embarrassment Avoidance Beliefs (e.g. ‘the
embarrassing nature of my symptoms prevents me from doing
things’), and Symptom Focusing, (e.g. ‘I think a great deal about my
symptoms’). Two behavioural subscales assessed ‘All or Nothing’
Behaviour (e.g. ‘I tend to overdo things and then rest up for awhile’)
and Avoidance/Resting (e.g. ‘when I experience symptoms, I rest’).
Statistical analyses
All analyses were performed using SPSS version 17.0 for Windows
(SPSS Inc.). Data were screened for outliers and missing values. No
transformations were judged necessary and all variables met criteria
for the assumptions of multivariate analysis [38].
Hierarchical multiple regression analyses were planned to deter-
mine the proportion of variance in the current depression (BDI-II)
accounted for by psychological variables, in addition to that explained
by the planned covariate of motor disability (PADLS). In order to reduce
the number of independent variables entered into the main regression
model, subscales of the IPQ-R and CBSQ were entered into separate
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depression symptom severity, as measured by the BDI-II (dependent
variable). Given the multiple variables, alpha level of the ﬁnal model
was set conservatively to 0.01.
Separately, logistic regression was planned to determine the stron-
gest predictors of depression status (BDI-II score ≥ 14). Predictors
were transformed into dichotomous variables, using their median as
the cut-off score. Although less sensitive than using continuous scores,
the ﬁndings provide accessible summaries of potential important pre-
dictors of outcome, even if conﬁdence intervals tend to be large.
Results
Participant characteristics
Of 173 patients invited, 104 returned completed analysable ques-
tionnaires. Of those not included, 15 declined to participate and 48 did
not respond. A further 11 participants were subsequently excluded,
ﬁve because the reported another major neurological disorders and
six because they returned incomplete datasets. Demographic and clini-
cal information for the total sample is summarised in Table 1 together
with the characteristics of the two subgroups. The ‘depressed’ sub-
groups had a signiﬁcantly younger age of onset of the PD (t(103) =
1.59, p = 0.006) and longer disease duration (t(103) = 2.87, p =
0.005). The self-reported disability (PADLS) was higher in the ‘de-
pressed’ group (Fishers Exact Test, probability = 0.003, Chi-square
(df= 3)= 13.31, p= 0.004). Moderate or severe functional difﬁculties
were reported by 54% of the ‘depressed’ subgroup compared to only
29.1% of the ‘non-depressed’ subgroup. The subgroups did not differ sig-
niﬁcantly in terms of age, gender or frequency of co-morbid physical
health conditions. Details of depression and other psychological vari-
ables are provided in Table 2. In total, 49.3% reported symptoms of de-
pression (BDI-II ≥ 14) with 26.9% in the moderate to severe range
(BDI-II ≥ 20). The ‘depressed’ subgroups scored signiﬁcantly higher
(t(103) N 2.70, p b 0.01) on all scales and subscales with the exception
of IPQ-R Identity, Illness Coherence and Control subscales, and CBSQ
Fear Avoidance subscale.
Preliminary linear regression analyses
The IPQ-R explained 31.2% of the variance in depression (R2 = 0.31,
F(11, 92)=3.79, p b .001). Of the subscales, Consequences emerged as a
signiﬁcant predictors of depression and was retained for the main anal-
ysis. The CBSQ explained 48.5% of the variance in depression (R2= 0.49,
F(5, 98) = 18.49, p b .001). Symptom Focusing and Avoidance/Resting
emerged as signiﬁcant predictors of depression severity and both
were retained. Table 3 shows the correlations matrix between the
BDI-II and the set of independent variables retained for inclusion in
the main regression analysis. All independent variables had inter-Table 1
Demographic and clinical characteristics (n = 104).
Variable Total sample (N = 104)
Mean (SD) or % Range
Age (years) 67.8 (8.5) 49–87
Gender (% male) 60 –
Age at PD onset (years) 58.1 (10.2) 35–79
Duration of PD (years since diagnosis) 10.0 (5.6) 3–28
Disability (PADLS) (%)
No difﬁculties 10.6 –
Mild difﬁculties 48.1 –
Moderate difﬁculties 30.8 –
Severe difﬁculties 10.6 –
OARS symptom count 2.2 (1.8) 0–8
PD: Parkinson's disease; PADLS: Parkinson's Activities of Daily Living Scale; OARS: Duke Oldercorrelation coefﬁcients of less than 0.66 (i.e. less than 44% shared
variance).
Main linear regression analysis: psychological predictors of depression
Table 4 displays the results of themain regressionmodel for psycho-
logical factors and disability on depression. The adjusted R2 (=0.708)
indicates that the variables in theﬁnal regression equation explained al-
most 71% of the variability in depression symptom severity (R2 = 0.73,
F(6, 97)= 42.6, p b .001), with psychological factors contributing 58.9%
to the variance. Rumination (RSS), Cognitive-behavioral Avoidance
(CBAS Total), and Avoidance/Resting and Symptom Focusing (CBSQ)
emerged as signiﬁcant predictors, but not dysfunctional attitudes and
beliefs (DAS-24). A secondary analysis of the CBAS showed that Behav-
ioral Social Avoidance was the only subscale to signiﬁcantly contribute
to depression variance.
Table 5 displays the results of the logistic regression analysis deter-
mining the relative contribution of psychological factors to the dichoto-
mous risk of being depressed (BDI-II ≥ 14), beyond that attributable to
differences in disability. Adjusted odds ratios (Exp B) and their 95% con-
ﬁdence intervals are presented for all variables, as well as Hosmer and
Lemeshow's R2 and the chi-square statistic for the ﬁnal model. Signiﬁ-
cance was determined using theWald statistic. The ﬁnal model correct-
ly classiﬁed 86.5% of cases (χ2 = 85.99, p b .001), with Hosmer and
Lemeshow's R2 value indicating that the model explained 59.7% of the
variance in depression outcome. The Hosmer and Lemeshow's
goodness-of-ﬁt test (χ2 = 10.18, p = .253) indicated that the ﬁnal re-
gression model ﬁtted the observed data. Signiﬁcant predictors of de-
pression in the ﬁnal model were high rumination, high cognitive-
behavioural avoidance, high symptom focusing, high avoidance/resting
and ‘all-or-nothing’ behaviour, although the conﬁdence intervals were
all large. Individuals who scored highly (total score N13) on rumination
were approximately 9.4 times (CI 2.26–39.31) more likely to be
depressed than low ruminators. High avoiders (total score N56) were
approximately 15.0 times (CI 3.07–71.00)more likely than low avoiders
to be depressed, and individuals who frequently focused on their
Parkinson's symptoms (total score N8) were approximately 6.0 times
(CI 1.57–25.57) more likely than individuals who focused on their
symptoms less frequently.
Discussion
This study examined the potential contributions of a range of
psychological factors to depression in Parkinson's disease, beyond that
explained by motor disability. Findings showed that psychological
factors account for a substantial proportion of variance in outcome.
The ﬁnding that cognitive and behavioural avoidance emerged as a
strong correlate of depression is consistent with many previous studies
in Parkinson's disease [11,12,20,39]. In particular, behavioural avoidance‘Non-depressed’ (BDI-II b 14)
(N = 53)
‘Depressed’ (BDI-II ≥ 14)
(N= 51)
Mean (SD) or % Range Mean (SD) or % Range
68.9 (8.4) 52–87 66.3 (8.4) 49–83
60 – 58 –
60.8 (8.8) 39–75 55.2 (10.8) 35–79
8.4 (4.7) 1–24 11.5 (6.2) 4–28
16.4 – 4.0 –
54.5 – 42.0 –
27.3 – 34.0 –
1.8 – 20.0 –
1.8 (1.4) 0–5 2.6 (2.0) 0–8
Americans Resources and Services Questionnaire.
Table 2
Depression and psychological variables (n = 104).
Variable
Total sample (N = 104)
Mean (SD)
‘Non-depressed’ (BDI-II b 14) (N = 53)
Mean (SD)
‘Depressed’ (BDI-II ≥ 14) (N = 51)
(Mean SD)
BDI-II total 14.1 (8.2) 7.9 (3.3) 20.8 (6.3)
DAS-24 total 85.7 (18.7) 79.8 (17.84) 92.2 (17.6)
RRS total 14.8 (11.2) 8.1 (7.2) 22.3 (10.1)
CBAS total 62.9 (22.2) 48.8 (12.0) 78.5 (20.4)
CBAS Behavioral Social scale 14.8 (7.0) 10.5 (3.5) 19.5 (6.1)
CBAS Behavioral Non-Social scale 13.9 (4.3) 11.4 (3.2) 16.7 (3.7)
CBAS Cognitive Social scale 13.2 (5.6) 10.2 (3.5) 16.6 (5.8)
CBAS Cognitive Non-Social scale 21.0 (7.5) 16.7 (4.9) 25.8 (7.0)
IPQ-R
Identity scale 6.9 (3.2) 6.3 (3.0) 7.5 (3.2)
Consequences scale 22.6 (4.3) 21.2. (4.4) 24.2. (3.7)
Timeline scale 39.5 (4.4) 38.4 (4.1) 40.6 (4.4)
Control scale 34.8 (5.4) 35.6 (5.8) 33.9 (5.0)
Illness coherence scale 16.6 (4.5) 16.8 (4.2) 16.3 (4.8)
CBSQ
Fear Avoidance scale 5.1 (3.6) 4.4 (3.4) 5.8 (3.8)
Embarrassment Avoidance scale 6.8 (4.0) 5.4 (3.7) 8.3 (3.7)
Symptom Focusing scale 7.3 (3.5) 5.5 (3.1) 9.2 (2.8)
All or Nothing scale 5.9 (3.7) 4.5 (3.4) 7.4 (3.5)
Avoidance/Resting scale 8.6 (5.2) 6.1 (4.0) 11.3 (4.9)
BDI-II: Beck Depression Inventory Second Edition; DAS-24: 24-item Dysfunctional Attitude Scale; CBAS: Cognitive and Behavioral Avoidance Scale; IPQ-R: Illness Perception
Questionnaire — Revised; RSS: Ruminative Response Scale; CBSQ: Cognitive and Behavioral Responses to Symptoms Scale.
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avoidance. Whether because of concerns such as falling in public or fear
of negative social evaluation concerning their Parkinson's symptoms, pa-
tients often avoid social situations. The initial short-term reduction of
stress and anxiety related to such situations can then develop over time
into a more chronic pattern of avoidance. The resultant isolation and
loss of opportunity for rewarding interactions may provide a plausible
mechanism for vulnerability to depression and maintaining depressed
mood once it occurs. Behavioural interventions within CBT approaches
for depression target such avoidant coping and seek to reintroduce a
range of social activity with associated beneﬁts for mood. The present
evidence supports such as strategy.
Novel ﬁndings in the present study were evidence of associations
between depression, rumination and symptom focusing in PD. Along
with avoidance, they emerged as strongly associated with depression
symptom severity and depression status. Rumination is a trait-like
self-reﬂective cognitive mode that involves ‘repetitively and passively
focusing one's symptoms of distress and on the possible causes and
consequences’ [40]. Rumination increases in depression, is associated
with the severity and duration of depressive episodes [41], and in-
creases the risk of depressive relapse in remitted patients [42], suggest-
ing it may be an important vulnerability factor. Moreover, once
depressed, rumination may serve to maintain negative affect through
the repetitive focus on negative events, problems and their implications
in the perceived absence of a solution. Rumination may develop as a
preferred way of coping with challenges and changing circumstances,
particularly for individuals who have difﬁculty tolerating uncertaintyTable 3
Inter-correlations between dependent and independent variables selected for the main linear
PADLS DAS CBAS RRS
BDI-II .357⁎⁎ .344⁎⁎ .778⁎⁎ .724⁎⁎
PADLS .116 .409⁎⁎ .240⁎
DAS-24 (total) .345⁎⁎ .445⁎⁎
CBAS (total) .656⁎⁎
RRS (total)
IPQ-R consequences
CBSQ symptom focusing
BDI-II: BeckDepression Inventory Second Edition; PADLS: Parkinson's Activities of Daily Living S
ance Scale; RRS: Ruminative Responses Scale; IPQ-R: Illness Perceptions Questionnaire Revised
⁎ p b .05.
⁎⁎ p b .01.and relinquishing or reappraising important life goals. The sense of
certainty and relief from responsibility that follows an appraisal of a
situation as hopeless may in turn reinforce the use of rumination as a
coping strategy. Thismight subsequently exacerbates pessimistic think-
ing and depressedmood, while inhibitingmore active problems solving
[43]. Metacognitive beliefs about the perceived positive value of rumi-
nation and other strategies haven been shown to occur in Parkinson's
disease and be associated with psychological distress [44,45].
The role of rumination as a psychological predictor of depression in
Parkinson's disease is also particularly relevant in light of its known,
and possibly reciprocal, association with attention and executive func-
tion [46,47]. Such cognitive deﬁcits, common in Parkinson's disease
[48], may exacerbate individuals' tendency to ruminate by further
inhibiting their ability to switch their attention from such think patterns
to more adaptive problem-solving strategies. However, there is no evi-
dence that the severity of executive dysfunction is predictive of re-
sponse to CBT in Parkinson's disease [49]. Neuroimaging evidence in
psychiatric patients with depressive disorder also points to abnormal
processing and network interactions involving anterior cingulate and
orbitofrontal cortex during rumination and self-referential processing
[50]. Pathophysiological changes in these same regions in Parkinson's
disease may predispose some patients to rumination and increase risk
of depression, even in the absence of cognitive impairment.
Symptom focusing (inwardly directed attention to physical symp-
toms of disease) was also associated with depression severity and de-
pression status, consistent with another recent report examining
anxiety and distress in Parkinson's disease [45]. Symptom focusing hasregression analyses.
IPQ consequences CBSQ symptom focus CBSQ avoidance/resting.
.365⁎⁎ .510⁎⁎ .588⁎⁎
.421⁎⁎ .148 .457⁎⁎
.050 .251⁎ .121
.326⁎⁎ .381⁎⁎ .542⁎⁎
.223 .499⁎⁎ .434⁎⁎
.291⁎⁎ .413⁎⁎
.368⁎⁎
cale; DAS-24: 24-itemDysfunctional Attitude Scale; CBAS Cognitive and Behavioral Avoid-
; CBSQ: Cognitive and Behavioral Responses to Symptoms Questionnaire.
Table 4
Final cross-sectional multiple linear regression model of psychological predictors and dis-
ease severity on depression symptom severity (BDI-II).
B SE B β
Constant −4.20 2.52
Disease severity (PADLS) 0.10 0.61 .010
Dysfunctional assumptions (DAS-24 total) 0.004 0.03 .009
Rumination (RRS total) 0.21 0.06 .292⁎⁎
Cognitive-behavioral avoidance (CBAS total) 0.16 0.03 .437⁎⁎
Avoidance/Resting (CBSQ) 0.27 0.11 .171⁎
Symptom focusing (CBSQ) 0.31 0.15 .131⁎
PADLS: Parkinson's Activities of Daily Living Scale; DAS-24: 24-item Dysfunctional Atti-
tude Scale; RRS: Ruminative Responses Scale; CBAS Cognitive and Behavioral Avoidance
Scale; CBSQ: Cognitive and Behavioral Responses to Symptoms Questionnaire.
⁎ p b .05, R2 = 0.725. Adjusted R2 = 0.708.
⁎⁎ p b .01, R2 = 0.725. Adjusted R2 = 0.708.
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thought to play a key maintaining role by increasing preoccupation
with bodily symptoms and perceptions of illness threat [51]. Symptom
focusing also correlated strongly here with cognitive-behavioural
avoidance and avoidance/resting, consistent with a hypothesis that
attentional somatic focus may lead to attempts to manage symptoms
by avoiding activity and/or engaging in excessive resting, and accompa-
nying positive beliefs about the value of such strategies.
Contrary to expectations, although dysfunctional assumptions were
associated with depressed mood, the effect size was small compared to
other factors studied (Table 3), and did not make a signiﬁcant indepen-
dent contribution to explaining depression inmultivariate analyses. It is
possible that dysfunctional assumptions play a more important role in
the initial onset of depression, which was not assessed in the current
study, while other processes, such as rumination and avoidance, are
more instrumental in maintaining and exacerbating depressive symp-
toms. The present ﬁnding is also consistent with the suggestion that it
is not the level of unhelpful beliefs that is key in the onset of depression
but rather the ease with which these beliefs are reactivated by low
mood, sometimes known as ‘cognitive reactivity’ [52].
The present study has implications for how future CBT interventions
might be tailored to the speciﬁc needs of people with Parkinson's dis-
ease, targeting potentially key maladaptive processes of rumination,
symptom focusing and cognitive-behavioural avoidance, with less
emphasis placed on cognitive distortions or dysfunctional beliefs or
assumptions. Such targeting may also offer the promise of briefer yet
still effective interventions. A range of possible ‘third-wave’ cognitive
therapies are emerging, designed speciﬁcally to target rumination and
relatedmetacognitive processes, particularlywhen depression is persis-
tent or recurrent. These include Rumination-focused CBT (RFCBT) [53]
Mindfulness-based CBT (MBCT) [54] and Metacognitive Therapy [55].
Group MBCT has been piloted in Parkinson's disease and a qualitative
study found the intervention to be beneﬁcial, particularly in relationTable 5
Final logistic regression model of psychological predictors and disease severity on depres-
sion status (BDI-II ≥ 14).
Exp (B)
(odds ratio)
95% C.I. for Exp
(B)
Constant 0.004
Motor disability (PADLS ≥2) 1.18 0.25–5.49
Dysfunctional assumptions (DAS-24 ≥85) 2.60 0.59–11.40
Rumination (RRS ≥13) 9.42** 2.26–39.31
Cognitive-behavioural avoidance (CBAS ≥56) 14.77** 3.07–71.00
Symptom focusing (CBSQ subscale ≥8) 6.33** 1.57–25.57
Avoidance/Resting (CBSQ subscale ≥9) 6.99* 1.50–32.60
All-or-nothing behaviour (CBSQ subscale ≥5) 4.74* 1.15–19.63
Note: R2 = .597; Model χ2 = 85.99, p b .001, *p b .05; **p b .01.
PADLS: Parkinson's Activities of Daily Living Scale; DAS-24: 24-item Dysfunctional Atti-
tude Scale; RRS: Ruminative Responses Scale; CBAS Cognitive and Behavioral Avoidance
Scale; CBSQ: Cognitive and Behavioral Responses to Symptoms Questionnaire.to developing and consolidating coping skills in the context of actual
loss, and perceived stigma than can drive avoidance [56].
Some limitations of the present study should be acknowledged. As a
postal survey, even with reasonable response rates, there is the
potential for selection bias. Future research should seek to recruit from
a consecutive clinic population, ideally with face-to-face assessment.
As the study only included participants with a score above 24 on the
MMSE, results may not be generalizable to depressed patients with sig-
niﬁcant cognitive impairment. The cross-sectional nature of the study
means that caution is necessary in inferring causality from the patterns
of association. Intervention studies that target speciﬁc components
would provide insights in the causal nature of the relationships as
well as inform clinical management.
In conclusion, the present study reinforces the important contribu-
tion of psychological factors to depression in Parkinson's disease. It
further indicates that clinical interventions that primarily target behav-
ioural, cognitive and metacognitive processes, including avoidance,
symptom focusing and rumination offer the potential to reduce depres-
sive symptoms or depression risk.
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